<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Anti Glaucoma Drugs</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Anti Glaucoma Drugs</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                16 Questions | 16 Total Marks | 26 min Duration | ~97.5 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 16 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 26 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 16</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Anti Glaucoma Drugs - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 16</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 16 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "Which of the following agents diminish intraocular pressure (IOP) during general anesthesia? Halothane Enflurane Isoflurane Ketamine Select the correct answer from the given below code:", "options": [{"label": "A", "text": "1, 2, and 3", "correct": true}, {"label": "B", "text": "1 and 3", "correct": false}, {"label": "C", "text": "2 and 4", "correct": false}, {"label": "D", "text": "1, 2, 3, and 4", "correct": false}], "correct_answer": "A. 1, 2, and 3", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>1, 2, and 3 Intravenous anaesthetics and volatile agents reduce intraocular pressure, except ketamine. Underlying mechanisms include a direct effect on cerebral IOP control centres and indirect effects mediated through the balance between production and drainage of aqueous humour, general circulation, and ocular muscle tone.</p>\n<p><strong>Random:</strong></p><p>Explanation for all options: - Statements 1 and 2 : The other agents usually cause a decreased IOP. Statement 3: Succinylcholine also can elevate IOP. Statement 4: Among these general anesthetic agents, ketamine alone is associated with increases in intraocular pressure (IOP) (primarily at high doses).</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The side effect of carbonic anhydrase inhibitors that is most commonly encountered is:", "options": [{"label": "A", "text": "Paresthesia", "correct": true}, {"label": "B", "text": "Kidney stones", "correct": false}, {"label": "C", "text": "Aplastic anemia", "correct": false}, {"label": "D", "text": "Hypocalcemia", "correct": false}], "correct_answer": "A. Paresthesia", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Paresthesia Carbonic anhydrase inhibitors (CAIs) reduce eye pressure by decreasing the production of intraocular fluid . They are classically used in the management of glaucoma due to their ability to reduce the secretion of aqueous humour , thereby lowering the intraocular pressure. Furthermore, CAIs are used not only for chronic open - angle glaucoma but also for acute angle - closure glaucoma before surgery. Paresthesias are reported by most patients taking these potent agents. The most common of all side effects is paresthesia.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Changes in urine pH secondary to carbonic anhydrase inhibitors can predispose a patient to calcium oxalate and calcium phosphate nephrolithiasis . Gastrointestinal distress occurs, but not most commonly. Option: C. Aplastic an a emia is a rare but potentially lethal side effect related to the sulfa derivation of the drugs. Option: D. Hypokalemia may occur as a result of the effects on renal ion transport, but Hypocalcemia is not seen.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Various glaucomatous subtypes are mentioned in the options below. Relative to patients with primary open-angle glaucoma (POAG), which of the following conditions is associated with an equal or better response to argon laser trabeculoplasty (ALT)? Aphakic glaucoma Pigmentary glaucoma Uveitic glaucoma Pseudoexfoliative glaucoma Select the correct answer from the given below code:", "options": [{"label": "A", "text": "1, 2, and 3", "correct": false}, {"label": "B", "text": "1 and 3", "correct": false}, {"label": "C", "text": "2 and 4", "correct": true}, {"label": "D", "text": "1, 2, 3, and 4", "correct": false}], "correct_answer": "C. 2 and 4", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>2 and 4 Argon laser trabeculoplasty (ALT) response appears to be better for pigmentary glaucoma and Pseudoexfoliation and poorer for inflammatory diseases, recessed angles, membranes in angles, young patients with developmental defects, and aphakic eyes.It is used to increase aqueous outflow facility through the trabecular meshwork in order to lower intraocular pressure.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Statement: A. Aphakic glaucoma is typically an open - angle glaucoma , adding weight to the proposition that an interaction occurs between trabecular meshwork cells and lens epithelial cells and/or the vitreous, leading to the development of elevated intraocular pressure Statement: B. Pigmentary glaucoma is a type of secondary open - angle glaucoma. Characterized by heavy homogeneous pigmentation of the trabecular meshwork, iris transillumination defects, and pigment along the corneal endothelium ( Krukenberg spindle ). Statement: C. Uveitic glaucoma is a common complication of uveitis, affecting some 20% of patients. The term ‚Äúuveitic glaucoma‚Äù is used to describe glaucoma resulting indirectly or directly from uveitis Glaucoma is more commonly associated anterior uveitis and with chronic forms of uveitis. Statement: D. Pseudoexfoliation glaucoma , or pseudoexfoliative glaucoma, is the same condition with the addition of elevated eye pressure and evidence of damage to the optic nerve. Pseudoexfoliation is not to be confused with ‚Äú true exfoliation, ‚Äùwhich is due to heat or infrared exposure (and which can be found among glassblowers). Pseudoexfoliation syndrome is a systemic disorder in which a fibrillar, proteinaceous substance is produced in abnormally high concentrations within ocular tissues. It is the most common cause of secondary glaucoma worldwide, and the most frequent cause of unilateral glaucoma.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which of the following miotics are direct-acting parasympathomimetic agents? Echothiophate Carbachol Demecarium Pilocarpine Select the correct answer from the given below code:", "options": [{"label": "A", "text": "1, 2, and 3", "correct": false}, {"label": "B", "text": "1 and 3", "correct": false}, {"label": "C", "text": "2 and 4", "correct": true}, {"label": "D", "text": "1, 2, 3, and 4", "correct": false}], "correct_answer": "C. 2 and 4", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>2 and 4 Direct - acting miotics interact directly with the acetylcholine receptor, whereas indirect - acting agents increase the activity of native acetylcholine at the synaptic junction (by blocking its enzymatic degradation).</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Statement 1 . Echothiophate: Echothiophate is an irreversible acetylcholinesterase inhibitor. Statement 2 . Carbachol, also known as carbamylcholine and sold under the brand name Miostat, among others, is a cholinomimetic drug that binds and activates acetylcholine receptors. Thus it is classified as a cholinergic agonist . Statement 3 . Demecarium : Demecarium bromide, trade name Humorsol, is a carbamate parasympathomimetic drug that acts as an acetylcholinesterase inhibitor , and is used as a glaucoma medication. It is applied directly to the eye in order to reduce elevated intraocular pressure associated with glaucoma. Statement 4: Pilocarpine is a purely direct agent, whereas carbachol is felt to exhibit both direct and indirect effects.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Drug not used in a hypertensive patient with glaucoma is:", "options": [{"label": "A", "text": "Acetazolamide", "correct": false}, {"label": "B", "text": "Beta blockers", "correct": false}, {"label": "C", "text": "Dipivefrin", "correct": true}, {"label": "D", "text": "Alpha agonist", "correct": false}], "correct_answer": "C. Dipivefrin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Dipivefrin Dipivefrin hydrochloride (AKPro, Propine) Converted to epinephrine in the eye by enzymatic hydrolysis. Appears to act by decreasing aqueous production and enhancing outflow facilities. has the same therapeutic effect as epinephrine with fewer local and systemic adverse effects. may be used as an initial therapy or as an adjunct with other anti - glaucoma agents for the control of IOP.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Acetazolamide, a carbonic anhydrase inhibitor, can be used in hypertensive patients. Option: B and D. Beta blockers and alpha agonists are used to lower blood pressure.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 36-years-old female on a prone dark room test develops pain in the eyes. Which of the following drugs should be avoided?", "options": [{"label": "A", "text": "Atropine", "correct": true}, {"label": "B", "text": "Pilocarpine", "correct": false}, {"label": "C", "text": "Acetazolamide", "correct": false}, {"label": "D", "text": "Mannitol", "correct": false}], "correct_answer": "A. Atropine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Atropine Atropine is mydriatic, which worsen the condition of an already dilated pupil in a dark room by making AC shallow and thereby increasing IOP. Primary angle closure glaucoma Mechanism- relative pupillary block (opposition of the pupillary margin against the lens surface in a mid-dilated pupil) causes obstruction of aqueous flow from PC to AC, resulting in iris bomber formation. Anterior iris bowing due to increased aqueous pressure in PC causes iridotrabecular corneal contact, which leads to peripheral anterior synechiae formation, resulting in PACG( central deep AC, peripheral shallow AC) Risk factors Hypermetropia Small cornea Shallow A Relative anterior position of lens: iris diaphragm Females are more prone. It gets precipitated by dim light, stress, near work, and mydriatics. Clinical features- Subacute ACG C/o transient BOV Coloured halos around light due to corneal epithelial edema Patients have shallow AC, and these symptoms occur more often at night, due to precipitating factors Acute ACG or acute congestive glaucoma Symptoms ; Severe pain radiates along the trigeminal nerve and may be associated with nausea, vomiting, profuse sweat. Redness Sudden LOV, BOV Signs IOP is markedly raised, 40 mm Hg to 60 mm Hg On digital tonometry, rock-hard eye Conjunctival hyperemia circumcorneal congestion Eclipse sign: shadow on nasal iris due to iris bombe Pupil: vertically oval, mid dilated, fixed due sphincter pupillae paralysis caused by raised IOP corneal edema Shallow AC with aqueous flare Sectoral iris atrophy with posterior synechiae Glaukomflecken: anterior capsular opacities due to lens epithelial ischemia or necrosis Visual fields constriction of the superior field Chronic ACG PAS may be seen on gonioscopy, usually broad based, causing angle closure more than 180¬∞. Creeping angle closure: circumferential, slow spread of synechiae closure form periphery towards Schwalbe line The visual field‚Äôs central nasal step is most commonly seen.</p>\n<p><strong>Highyeild:</strong></p><p>Provocative test- Prone dark room test: In this baseline IOP is measurement,  the patient is made to lie prone in the darkroom for 1 hour. He must be awake; after 1 hour, IOP is again recorded . An increase in IOP of more than 8 mm Hg is considered as diagnostic.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: A. Pilocarpine 1% or 2% drops acts by opening the angle Following which, assess the corneal activity of clear laser iridotomy and, if hazy, proceed to peripheral iridoplasty and laser pupilloplasty. Option: C. Acetazolamide 250 mg, 2 tabs Glycerin orally, 1 - 1.5 g/kg body weight Option: D. IV mannitol, 1- 2 g/ kg, 25% solution over 30 min. Is the</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 56-year-old male glaucomatous patient with a previous history of herpes simplex keratitis was prescribed with topical timolol 0.5% to be used daily. Topical Œ≤-adrenergic antagonists are known to be associated with all of the following side effects except:", "options": [{"label": "A", "text": "Increased plasma high-density lipoprotein cholesterol levels", "correct": true}, {"label": "B", "text": "Bronchospasm and airway obstruction", "correct": false}, {"label": "C", "text": "Weakened myocardial contractility", "correct": false}, {"label": "D", "text": "Exercise intolerance", "correct": false}], "correct_answer": "A. Increased plasma high-density lipoprotein cholesterol levels", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Increased plasma high-density lipoprotein cholesterol levels Topical timolol has been shown to decrease plasma high-density lipoprotein cholesterol levels. Timolol is a non selective beta - adrenergic antagonist given in an eye drop solution to reduce intraocular pressure in eyes. Mechanism of action : Reduction of the formation of aqueous humor in the ciliary body in the eye.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: B. Blockade of Œ≤2 - adrenergic receptors produces contraction of the bronchial smooth muscle. Betaxolol is relatively Œ≤1 - selective and may have less of an effect on the respiratory muscles. Option: C. Carteolol is a topical nonselective Œ≤ - adrenergic antagonist that has intrinsic sympathomimetic activity and has been shown to have a less adverse effect on plasma lipids. Option: D. Blockade of Œ≤1 - adrenergic receptors slows the pulse rate and weakens myocardial contractility, which can affect the time of exhaustion with heavy exercise.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 67yearold male presents with glaucoma refractory to initial medical management. Apraclonidine eye drops were prescribed. This medication has all of the following side effects except:", "options": [{"label": "A", "text": "Systemic Hypotension", "correct": true}, {"label": "B", "text": "Superior lid retraction", "correct": false}, {"label": "C", "text": "Dry mouth", "correct": false}, {"label": "D", "text": "Blanching of conjunctival vessels", "correct": false}], "correct_answer": "A. Systemic Hypotension", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Systemic Hypotension Apraclonidine hydrochloride is a para-amino derivative of clonidine. hydrochloride, an Œ±2 - adrenergic agonist that is used clinically as a potent systemic antihypertensive agent . Several studies have shown the lack of effect of apraclonidine on blood pressure and pulse Apraclonidine 5% eye drops are used for the short-term treatment of glaucoma in people who are taking other medications for this condition and still have an increased IOP. Upon ocular administration, apraclonidine enhances aqueous humour uveoscleral outflow and decreases aqueous production by vasoconstriction. This may decrease intraocular pressure.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option: C. However, a transient dry mouth or dry nose is commonly reported. Option: B & D. Ocular side effects include eyelid retraction, mydriasis, and conjunctival blanching.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Below image shows a topical medication used for the management of chronic cases of glaucoma. Which of the given options perfectly describes it‚Äôs predominant mechanism of action:", "options": [{"label": "A", "text": "Increased Uveoscleral Outflow", "correct": true}, {"label": "B", "text": "Enhanced aqueous outflow by stimulation of ciliary muscle contraction", "correct": false}, {"label": "C", "text": "Reduced vitreous volume", "correct": false}, {"label": "D", "text": "Reduced aqueous production", "correct": false}], "correct_answer": "A. Increased Uveoscleral Outflow", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1685017895855-QTDO022009IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Increased Uveoscleral Outflow The prostaglandin analogs , of which Latanoprost is a member, appear to lower IOP by increasing uveoscleral outflow . Aqueous outflow follows both conventional and nonconventional pathways. The conventional pathway , which accounts for 85% to 90% of aqueous outflow, consists of the trabecular meshwork , Schlemm canal, and episcleral/conjunctival veins. The unconventional pathway‚Äôs principal route is via the uveal tract and sclera. This accounts for about 10% to 15% of total outflow. Whereas conventional outflow is dependent on the baseline level of IOP, the unconventional pathway is not.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 67-year-old male was recently treated with filtration surgery due to long standing glaucoma. After the surgery, postoperative hypotony was detected. The following measures can be taken to limit postoperative hypotony with the device in the image below, except:", "options": [{"label": "A", "text": "Two-Stage Procedure", "correct": false}, {"label": "B", "text": "Collagen plugs", "correct": false}, {"label": "C", "text": "Pressure-sensitive valve", "correct": true}, {"label": "D", "text": "Ligature occlusion of tube", "correct": false}], "correct_answer": "C. Pressure-sensitive valve", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1685017908386-QTDO022010IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Pressure-sensitive valve The Baerveldt implant , as shown in the given image, does not have a pressure-sensitive valve, so hypotony in the early postoperative period has to be managed by other means. Hypotony is common when drainage implants are installed in a one-stage procedure without complete tube occlusion. The absence of any resistance to aqueous outflow invariably results in a reduction of IOP to below physiologic levels. A two-stage procedure has been recommended to limit early hypotony. During the first operation, the scleral plate is sutured to the globe without connecting the tube to the anterior chamber. This procedure is followed by a second operation 2 to 8 weeks later, during which the tube is inserted into the anterior chamber. An alternative to limiting over filtration after one-stage installation involves the temporary occlusion of the tube lumen with a ligature or with semipermeable, biodegradable collagen lacrimal plugs.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 29-year-old woman was brought to the emergency department with respiratory difficulty for an hour. On examination, the respiratory rate was 34 per minute. On auscultation, there was wheezing heard on both sides. salbutamol inhalation was given, and the patient